companydata.dkcompanydata.dk

Signum Life Science ApS: Financial statements 2025

CVR: 36559241

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589. The solvency ratio was 71.8%. The company had 43 employees in the financial year.

Gross Profit
DKK -67,441,461
Profit/Loss
DKK -66,049,966
Equity
DKK 40,680,589
Total Assets
DKK 56,661,472
Employees
43

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--67.4M-66M40.7M43
2024--1.9M-5.9M106.8M41
2023-1.5M-3.1M112.7M41
2022--184K-11.3M115.8M36
2021-7.6M1.3M128.5M34

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Signum Life Science ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Henrik Vestergaard joins Signum Life Science ApS as adm. dir.Oct 1, 2025

As of October 1, 2025, Henrik Vestergaard is registered as adm. dir. of Signum Life Science ApS.

Ida Sofie Jensen steps down as adm. dir. of Signum Life Science ApSSep 30, 2025

As of September 30, 2025, Ida Sofie Jensen has stepped down as adm. dir. of Signum Life Science ApS.

Signum Life Science ApS: The 2024 annual report is outMay 16, 2025

Signum Life Science ApS has published its annual report for 2024. Gross profit came to DKK -1,866,160, and the net result was DKK -5,936,982.

Julie Enevold Brooker joins the board of Signum Life Science ApSApr 14, 2025

As of April 14, 2025, Julie Enevold Brooker has joined the board of directors of Signum Life Science ApS.

Anja Cecilie Verhaug joins the board of Signum Life Science ApSApr 14, 2025

As of April 14, 2025, Anja Cecilie Verhaug has joined the board of directors of Signum Life Science ApS.

Thomas Bo Bjørn Klee leaves the board of Signum Life Science ApSApr 14, 2025

As of April 14, 2025, Thomas Bo Bjørn Klee has left the board of directors of Signum Life Science ApS.

Mari-Ann Retz leaves the board of Signum Life Science ApSApr 14, 2025

As of April 14, 2025, Mari-Ann Retz has left the board of directors of Signum Life Science ApS.

About Signum Life Science ApS

Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.

Source: annual report 2025, Danish Business Authority